Alnylam Stays Mum On APOLLO-B Amid Anticipation Over Major Readout
Results Could Expand Onpattro’s Market Fivefold
The company announced a respectable increase in second quarter sales and expects to announce topline results within the next three weeks for the Phase III trial of Onpattro in ATTR-CM.
